Ronald Lautner

2.6k total citations · 1 hit paper
14 papers, 1.8k citations indexed

About

Ronald Lautner is a scholar working on Physiology, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Ronald Lautner has authored 14 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 9 papers in Psychiatry and Mental health and 3 papers in Molecular Biology. Recurrent topics in Ronald Lautner's work include Alzheimer's disease research and treatments (10 papers), Dementia and Cognitive Impairment Research (9 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Ronald Lautner is often cited by papers focused on Alzheimer's disease research and treatments (10 papers), Dementia and Cognitive Impairment Research (9 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Ronald Lautner collaborates with scholars based in Sweden, United Kingdom and United States. Ronald Lautner's co-authors include Kaj Blennow, Henrik Zetterberg, Bob Olsson, Ulf Andréasson, Christoffer Rosén, Erik Portelius, Max Petzold, Maria Bjerke, Caroline Olsson and Elizabeth Wu and has published in prestigious journals such as The Lancet Neurology, Neurobiology of Aging and JAMA Psychiatry.

In The Last Decade

Ronald Lautner

14 papers receiving 1.8k citations

Hit Papers

CSF and blood biomarkers for the diagnosis of Alzheimer's... 2016 2026 2019 2022 2016 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
    2016 1.4k citations Bob Olsson, Ronald Lautner et al. The Lancet Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ronald Lautner Sweden 10 1.1k 688 533 392 260 14 1.8k
Niki S.M. Schoonenboom Netherlands 22 1.3k 1.2× 1.0k 1.5× 435 0.8× 530 1.4× 283 1.1× 37 2.1k
Mikko Hölttä Sweden 14 1.1k 1.0× 619 0.9× 979 1.8× 343 0.9× 281 1.1× 21 2.3k
Anniina Snellman Finland 19 1.2k 1.1× 830 1.2× 394 0.7× 307 0.8× 165 0.6× 44 1.7k
Gabrielle Strobel United States 4 874 0.8× 566 0.8× 435 0.8× 291 0.7× 207 0.8× 11 1.5k
Maartje I. Kester Netherlands 22 1.1k 1.0× 898 1.3× 356 0.7× 445 1.1× 391 1.5× 35 1.7k
Nathalie Le Bastard Belgium 24 1.3k 1.2× 1.1k 1.6× 425 0.8× 306 0.8× 345 1.3× 61 2.0k
Christoffer Rosén Sweden 13 1.4k 1.3× 975 1.4× 741 1.4× 485 1.2× 433 1.7× 14 2.4k
Juan Manuel Maler Germany 25 1.5k 1.4× 851 1.2× 742 1.4× 514 1.3× 258 1.0× 59 2.3k
Nicholas K. Proctor United States 6 1.2k 1.1× 983 1.4× 365 0.7× 351 0.9× 163 0.6× 7 1.7k
Giuseppe Tosto United States 20 663 0.6× 547 0.8× 446 0.8× 319 0.8× 175 0.7× 66 1.5k

Countries citing papers authored by Ronald Lautner

Since Specialization
Citations

This map shows the geographic impact of Ronald Lautner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald Lautner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald Lautner more than expected).

Fields of papers citing papers by Ronald Lautner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald Lautner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald Lautner. The network helps show where Ronald Lautner may publish in the future.

Co-authorship network of co-authors of Ronald Lautner

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald Lautner. A scholar is included among the top collaborators of Ronald Lautner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald Lautner. Ronald Lautner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Mattsson, Niklas, Olof Lindberg, Michael Schöll, et al.. (2018). Effects of APOE ε4 on neuroimaging, cerebrospinal fluid biomarkers, and cognition in prodromal Alzheimer's disease. Neurobiology of Aging. 71. 81–90. 14 indexed citations
2.
Skillbäck, Tobias, Ronald Lautner, Niklas Mattsson, et al.. (2018). Apolipoprotein E genotypes and longevity across dementia disorders. Alzheimer s & Dementia. 14(7). 895–901. 9 indexed citations
3.
Lautner, Ronald, Philip S. Insel, Tobias Skillbäck, et al.. (2017). Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations. Alzheimer s Research & Therapy. 9(1). 87–87. 19 indexed citations
4.
Olsson, Bob, Ronald Lautner, Ulf Andréasson, et al.. (2016). CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis. The Lancet Neurology. 15(7). 673–684. 1415 indexed citations breakdown →
5.
Gren, Magnus, Pashtun Shahim, Ronald Lautner, et al.. (2016). Blood biomarkers indicate mild neuroaxonal injury and increased amyloidβproduction after transient hypoxia during breath-hold diving. Brain Injury. 30(10). 1226–1230. 25 indexed citations
6.
Lautner, Ronald, Sebastian Palmqvist, Niklas Mattsson, et al.. (2014). Apolipoprotein E Genotype and the Diagnostic Accuracy of Cerebrospinal Fluid Biomarkers for Alzheimer Disease. JAMA Psychiatry. 71(10). 1183–1183. 75 indexed citations
7.
Blennow, Kaj, Niklas Mattsson, Ronald Lautner, et al.. (2014). O2‐05‐02: AMYLOID BIOMARKERS FOR AD: CURRENT STATUS AND NOVEL FINDINGS. Alzheimer s & Dementia. 10(4S_Part_2). 4 indexed citations
8.
Zetterberg, Henrik, Ronald Lautner, Tobias Skillbäck, et al.. (2014). CSF in Alzheimer's Disease. Advances in clinical chemistry. 65. 143–172. 17 indexed citations
9.
Tumani, Hayrettin, Axel Petzold, Manfred Wick, et al.. (2013). Cerebrospinal fluid analyses for the diagnosis of subarachnoid haemorrhage and experience from a Swedish study. What method is preferable when diagnosing a subarachnoid haemorrhage?. Clinical Chemistry and Laboratory Medicine (CCLM). 51(11). 2073–2086. 31 indexed citations
10.
Shahim, Pashtun, Andrea E. Bochem, Niklas Mattsson, et al.. (2013). Plasma Amyloid-β in Patients with Tangier Disease. Journal of Alzheimer s Disease. 35(2). 307–312. 2 indexed citations
11.
Andréasson, Ulf, Ronald Lautner, Jonathan M. Schott, et al.. (2013). P1–061: CSF biomarkers for Alzheimer's pathology and the effect size of APOE‐ε4. Alzheimer s & Dementia. 9(4S_Part_4). 1 indexed citations
12.
Daborg, Jonny, Ulf Andréasson, Marcela Pekna, et al.. (2012). Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer’s disease. Journal of Neural Transmission. 119(7). 789–797. 69 indexed citations
13.
Olsson, Bob, Joakim Hertze, Ronald Lautner, et al.. (2012). Microglial Markers are Elevated in the Prodromal Phase of Alzheimer's Disease and Vascular Dementia. Journal of Alzheimer s Disease. 33(1). 45–53. 99 indexed citations
14.
Lautner, Ronald, Niklas Mattsson, Michael Schöll, et al.. (2011). Biomarkers for Microglial Activation in Alzheimer′s Disease. International Journal of Alzheimer s Disease. 2011(1). 939426–939426. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Niki S.M. Schoonenboom Breakdown of academic impact, for papers by Mikko Hölttä Breakdown of academic impact, for papers by Anniina Snellman Breakdown of academic impact, for papers by Gabrielle Strobel Breakdown of academic impact, for papers by Maartje I. Kester Breakdown of academic impact, for papers by Nathalie Le Bastard Breakdown of academic impact, for papers by Christoffer Rosén Breakdown of academic impact, for papers by Juan Manuel Maler Breakdown of academic impact, for papers by Nicholas K. Proctor Breakdown of academic impact, for papers by Giuseppe Tosto
Rankless by CCL
2026